Please assess the completion status of the following clinical trial:

Trial Title: Comparison of Lactobacillus Reuteri and Nystatin Prophylaxis on Candida Colonization and Infection in Very Low Birth Weight Infants

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: SINGLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Very low birth weight infants \< 1500 gr~* Gestational age \< 32 weeks~Exclusion Criteria:~* Genetic anomalies~* Short bowel syndrome~* Not willing to participate~* Allergy to Lactobacillus reuteri components

- Gender: ALL
- Minimum Age: 1 Day
- Maximum Age: 6 Months
- Healthy Volunteers: f

Study Arms:
- Lactobacillus reuteri (Type: EXPERIMENTAL): Lactobacillus reuteri 100 million CFU/day for 3 months
- Nystatin (Type: ACTIVE_COMPARATOR): 50000 unit/3 times a day

Based on this trial design, predict the completion outcome and termination type (if applicable).